Cargando…
Expression of Chimeric HPV-HIV Protein L1P18 in Pichia pastoris; Purification and Characterization of the Virus-like Particles
Currently, three human papillomavirus (HPV) vaccines are already licensed and all of them are based on virus-like particles (VLPs) of HPV L1 capsid protein but not worldwide accessible. While about 38.0 million people were living with HIV in 2019, only 68% of HIV-infected individuals were accessing...
Autores principales: | Eto, Yoshiki, Saubi, Narcís, Ferrer, Pau, Joseph-Munné, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622379/ https://www.ncbi.nlm.nih.gov/pubmed/34834382 http://dx.doi.org/10.3390/pharmaceutics13111967 |
Ejemplares similares
-
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice
por: Chen, Chun-Wei, et al.
Publicado: (2023) -
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
por: Chen, Chun-Wei, et al.
Publicado: (2022) -
Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020) -
Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the Pichia pastoris
por: Gupta, Jyoti, et al.
Publicado: (2020) -
Development of quantitative metabolomics for Pichia pastoris
por: Carnicer, Marc, et al.
Publicado: (2011)